Combinatorial chemistry in cancer research

Clinical and Translational Oncology

Volumn 9, Issue 2, 2007, Pages 83-92

  Messeguer, A ^a   Cortes N ^a  

^a DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

Cancer; Chemical libraries; Combinatorial chemistry; Drug discovery; Lead compounds

Indexed keywords

1,3 DIOXANE DERIVATIVE; 2 ACETAMIDO THIAZOLYLTHIO ACETIC ESTER; AMIDE; AMINOBENZIMIDAZOLE PYRIMIDINE DERIVATIVE; CHLOROQUINE; CYC 200; CYCLIN DEPENDENT KINASE INHIBITOR; DEXVERAPAMIL; EMOPAMIL; FLAVOPIRIDOL; GLYCOPROTEIN P INHIBITOR; IMATINIB; LANIQUIDAR; N [5 (5 TERT BUTYL 2 OXAZOLYLMETHYLTHIO) 2 THIAZOLYL]ISONIPECOTAMIDE; N PHENYLACETYL 2 AMINOTHIAZOLE; NILOTINIB; NOVOBIOCIN; NOVOBIOCIN DERIVATIVE; OC 144 093; ONT 093; PEPTOID; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE INHIBITOR; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; ROSCOVITINE; TARIQUIDAR; UNINDEXED DRUG; VALSPODAR; VERAPAMIL; ZOSUQUIDAR; CYCLIN DEPENDENT KINASE; PROTEIN TYROSINE KINASE;

ALGORITHM; ANTIBIOTIC RESISTANCE; ANTINEOPLASTIC ACTIVITY; CANCER RESEARCH; CHEMICAL GENETICS; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COMBINATORIAL CHEMISTRY; COMBINATORIAL LIBRARY; COMPUTER AIDED DESIGN; DRUG APPROVAL; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; GASTROINTESTINAL STROMAL TUMOR; GENETIC ANALYSIS; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; UNSPECIFIED SIDE EFFECT; DRUG ANTAGONISM; DRUG RESISTANCE; MEDICAL RESEARCH; METHODOLOGY; NEOPLASM;

BIOMEDICAL RESEARCH; COMBINATORIAL CHEMISTRY TECHNIQUES; CYCLIN-DEPENDENT KINASES; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; PROTEIN-TYROSINE KINASES;

EID: 34347238631     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-007-0017-4     Document Type: Review

References (80)

1. Aherne GW, McDonald E, Workman P (2002) Finding the needle in the haystack: Why highthroughput screening is good for your health. Breast Cancer Res 4:148
2. Garret MD, Workman P (1999) Discovering novel chemotherapeutic drugs for the third millennium. Eur J Cancer 35:2010-2030
3. Wooster R (2001) Richard Wooster on cancer and the Human Genome Project. Lancet Oncol 2:176-178
4. Workman P (2001) New drug targets for genomic cancer therapy: Successes, limitations, opportunities and future challenges. Curr Cancer Drug Targets 1:33-47
5. Service RF (1996) Combinatorial chemistry hits the drug market. Science 272:1266-1268
6. Pavia MR, Sawyer TK, Moos WH (1993) The generation of molecular diversity. Bioorg Med Chem Lett 3:387-396
7. Wilson SR, Czanik AW (1997) Combinatorial chemistry: Synthesis and application. John Wiley & Sons, Inc., New York
8. Terret NK (1998) Combinatorial chemistry. Oxford University Press, Oxford, New York, Tokyo
9. Geysen HM, Meloen RH, Barteling SJ (1984) Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA 81:3998-4002
10. Houghten RA (1985) General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci USA 82:5131-5135
11. Furka Á, Sebestyén F, Asgedom M, Dibó G (1991) General method for rapid synthesis of multicomponent peptide mixtures. Int J Peptide Prot Res 37:487-493
12. Jung G, Beck-Sickinger AG (1992) Multiple peptide synthesis methods and their applications. Angew Chem Int Ed 31:367-486
13. Wyatt JR, Vickers TA, Roberson JL et al (1994) Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc Natl Acad Sci USA 91:1356-1360
14. Davis PW, Vickers TA, Wilson-Lingardo L et al (1995) Drug leads from combinatorial phosphodiester libraries. J Med Chem 38:4363-4366
15. Schneider DJ, Feigon J, Hostomsky Z, Gold L (1995) High-affinity ssDNA inhibitors of reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 34:9599-9610
16. Bunin BA, Ellman JA (1992) A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives. J Am Chem Soc 114:10997-10998
17. Thompson LA, Ellman JA (1996) Synthesis and applications of small molecule libraries. Chem Rev 96:555-600
18. Balkenhohl F, von dem Bussche-Hünnefeld C, Lansky A, Zechel C (1996) Combinatorial synthesis of small organic molecules. Angew Chem Int Ed 35:2288-2337
19. Zuckermann RN, Martin EJ, Spellmeyer DC et al (1994) Discovery of nanomolar ligands for transmembrane G-protein-coupled from a diverse N-(substituted)glycine peptoid library. J Med Chem 37:2678-2685
20. Bailey N, Dean AW, Judd DB et al (1996) A convenient procedure for the solution phase preparation of 2-aminothiazole combinatorial libraries. Bioorg Med Chem Lett 6:1409-1414
21. Han H, Janda KD (1996) Azatides: Solution and liquid phase syntheses of a new peptidomimetic. J Am Chem Soc 118:2539-2544
22. Martin SW, Romine JL, Chen L et al (2004) Application of solution-phase parallel synthesis to preparation of trisubstituted 1,2,4-triazoles. J Comb Chem 6:35-37
23. Norman TC, Gray NS, Koh JT, Schultz PG (1996) A structure-based library approach to kinase inhibitors. J Am Chem Soc 118:7430-7431
24. Frank R, Doring R (1988) Simultaneous multiple peptide synthesis under continuous flow conditions on cellulose paper discs as segmental solid supports. Tetrahedron 44:6031-6040
25. Heine N, Ast T, Schneider-Mergener J et al (2003) Synthesis and screening of peptoid arrays on cellulose membranes. Tetrahedron 59:9919-9930
26. Fodor SPA, Read JL, Pirrung MC et al (1991) Light-directed spatially addressable parallel chemical synthesis. Science 251:767-773
27. Lam KS, Salmon SE, Hersh EM et al (1991) A new type of synthetic peptide library for identifying ligand-binding activity. Nature 354:82-84
28. Lam KS, Lebl M, Krchnak V (1997) The "onebead- one-compound" combinatorial library method. Chem Rev 97:411-448
29. Dooley CT, Houghten RA (1993) The use of positional scanning synthetic peptide library for the rapid determination of opioid receptor ligands. Life Sci 52:1509-1517
30. Pinilla C, Appel JR, Blondelle SE et al (1994) Versatility of positional scanning synthetic combinatorial libraries for the identification of individual compounds. Drug Dev Res 33:133-145
31. Clemons PA, Koehler AN, Wagner BK et al (2001) A one-bead, one-stock solution approach to chemical genetics: Part 2. Chem Biol 8: 1183-1195
32. Strausberg RL, Schreiber SL (2003) From knowing to controlling: A path from genomics to drugs using small molecules probes. Science 300:294-295
33. Shuker DE (2004) Chemical genetics. Annu Rep Prog Chem Sect B 100:191-205
34. Langer T, Wolber G (2004) Virtual combinatorial chemistry and in silico screening: Efficient tools for lead structure discovery? Pure Appl Chem 76:991-996
35. Dearden JC (2003) In silico prediction of drug toxicity. J Comput Aided Mol Des 17:119-127
36. Druker BJ (2002) Perspectives on the development of a molecularly targeted agent. Cancer Cell 1:31-36
37. Rowley JD (1973) A new consistent abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and giemsa staining. Nature 243:290-293
38. Bartram CR, Klein A, Hagemeijer A et al (1983) Translocation of c-abl correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature 306:277-280
39. Buchdunger E, Zimmermann J, Mett H et al (1995) Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2- phenylaminopyrimidine class. Proc Natl Acad Sci USA 92:2558-2562
40. Zimmermann J, Caravatti G, Mett H et al (1996) Phenylamino-pyrimidine (PAP) derivatives: A new class of potent and selective inhibitors of protein kinase C (PKC). Arch Pharm 329:371-376
41. Druker BJ, Lydon NB (2000) Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest 105:3-7
42. van Oosterom AT, Judson I, Verweij J et al (2001) Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: A phase I study. Lancet 358:1421-1423
43. Weisberg E, Griffin JD (2003) Resistance to imatinib (Glivec): Update on clinical mechanisms. Drug Resist Updat 6:231-238
44. O'Hare T, Walters DK, Deininger MWN, Druker BJ (2005) AMN107: Tightening the grip of imatinib. Cancer Cell 7:117-119
45. Bradeen HA, Eide CA, O'Hare T et al (2006) Comparison of imatinib mesylate, desatinib (BMS-354825), and nilotinib (AMN107) in a Nethyl- N-nitrosourea (ENU)-based mutagenesis screen: High efficacy of drug combinations. Blood 108:2332-2338
46. Morgan DO (1995) Principles of CDK regulation. Nature 374:131-134
47. Nasmyth K (1996) Viewpoint: Putting the cell cycle in order. Science 274:1643-1645
48. Boulamwini JK (2000) Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Design 6:379-392
49. Kim KS, Kimball D, Misra RN et al (2002) Discovery of aminothiazole inhibitors of cyclindependent kinase 2: Synthesis, X-ray crystallographic analysis, and biological activities. J Med Chem 45:3905-3927
50. Zhai S, Senderowicz AM, Sausville EA, Figg WD (2002) Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development. Ann Pharmacother 36:905-911
51. Misra RN, Xiao H-Y, Kim KS et al (2004) N- (Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5 [5- (1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-t hiazo lyl]-4-piperidinecarboxamide (BMS- 387032), a highly efficacious and selective antitumor agent. J Med Chem 47:1719-1728
52. Noble MEM, Endicott JA, Johnson LN (2004) Protein kinase inhibitors: insights into drug design from structure. Science 303:1800-1805
53. Meijer L, Raymond E (2003) Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc Chem Res 36: 417-425
54. Pastan I, Gottesmann M (1987) Multidrug resistance in human cancer. N Engl J Med 316:1388-1393
55. Ling V (1997) Multidrug resistance: Molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40:S3-S8
56. Bellamy WT (1996) P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol 36:161-183
57. Ramachandran C, Melnick SJ (1999) Multidrug resistance in human tumors-molecular diagnosis and clinical significance. Mol Diagn 4:81-94
58. Tan B, Piwnica-Worms D, Ratner L (2000) Multidrug resistance transporters and modulation. Curr Opin Oncol 12:450-458
59. Robert J, Jarry C (2003) Multidrug resistance reversal agents. J Med Chem 46:4805-4817
60. Borowski E, Bontemps-Gracz MM, Piwkowska A (2005) Strategies for overcoming ABC-transporters- mediated multidrug resistance (MDR) of tumor cells. Acta Biochim Pol 52:609-627
61. Krishna R, Mayer LD (2001) Modulation of P-glycoprotein (PGP) mediated multidrug resistance (MDR) using chemosensitizers: Recent advances in the design of selective MDR modulators. Curr Med Chem Anti-Canc Agents 1:163-174
62. Newman MJ, Rodarte JC, Benbatoul KD et al (2000) Discovery and characterization of OC144-093, a novel inhibitor of P-glycoproteinmediated multidrug resistance. Cancer Res 60: 2964-2972
63. Bhattacharyya S (2001) Combinatorial approaches in anticancer drug discovery: Recent advances in design and synthesis. Curr Med Chem 8:1383-1404
64. Boger DL, Chai W, Jin Q (1998) Multistep convergent solution-phase combinatorial synthesis and deletion synthesis deconvolution. J Chem Soc 120:7220-7225
65. Nicolaou KC, Winssinger N, Vourloumis D et (1998) Solid and solution phase synthesis and biological evaluation of combinatorial sarcodictyin libraries. J Am Chem Soc 120:10814-10826
66. Bhat L, Liu Y, Victory SF et al (1998) Synthesis and evaluation of paclitaxel C7 derivatives: Solution phase synthesis of combinatorial libraries. Bioorg Med Chem Lett 8:3181-3186
67. Meseguer B, Alonso-Díaz D, Griebenow N et (1999) Natural product synthesis on polymeric supports - synthesis and biological evaluation of an indolactam library. Angew Chem Int Ed 38: 2902-2906
68. Abato P, Conroy JL, Seto CT (1999) Combinatorial library of serine and cysteine protease inhibitors that interact with both the S and S' binding sites. J Med Chem 42:4001-4009
69. Dolle RE, Le Bourdonnec BL, Morales GA et al (2006) Comprehensive survey of combinatorial library synthesis. J Comb Chem 8:597-635
70. Pagliai F, Pirali T, Del Grosso E et al (2006) Rapid synthesis of triazole-modified resveratrol analogues via click chemistry. J Med Chem 49: 467-470
71. Jang M, Cai L, Udeani GO et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220
72. Abad-Merin MJ, Cortés N, Masip I et al (2005) Trimers of N-alkylglycines are potent modulators of the multidrug resistance phenotype. J Pharmacol Exp Ther 313:112-120
73. Masip I, Cortés N, Abad-Merin MJ et al (2005) Design and synthesis of an optimised positional scanning library of peptoids: Identification of novel multidrug resistance reversal agents. Bioorg Med Chem 13:1923-1929
74. Parks DJ, LaFrance LV, Calvo RR et al (2005) 1,4-Benzodiazepine-2,5-diones as small molecules antagonists of the HDM2-p53 interaction: Discovery and SAR. Bioorg Med Chem Lett 15:765-770
75. Yu XM, Shen G, Neckers L et al (2005) Hsp90 inhibitors identified from a library of novobiocin analogues. J Am Chem Soc 127:12778-12779
76. Verma S, Nagarathnam D, Shao J et al (2005) Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors. Bioorg Med Chem Lett 15:1973-1977
77. Rokosz LL, Huang C-Y, Reader JC et al (2005) Surfing the piperazine core of tricyclic farnesyltransferase inhibitors. Bioorg Med Chem Lett 15:5537-5543
78. Dothager RS, Putt KS, Allen BJ et al (2005) Synthesis and identification of small molecules that potently induce apoptosis in melanoma cells through G1 cell cycle arrest. J Am Chem Soc 127: 8686-8696
79. Owa T, Yokoi A, Yamazaki K et al (2002) Arraybased structure and gene expression relationship study of antitumour sulfonamides including N- [2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4- methoxybenzenesulfonamide and N-(3-chloro- 7-indolyl)-1,4-benzenedisulfonamide. J Med Chem 45:4913-4922
80. Sternson SM, Wong JC, Grozinger CM, Schreiber SL (2001) Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin. Org Lett 3:4239-4242